The cost of sequencing the entire human genome, or exome - the regions of the genome that are translated into proteins that affect cell behavior - has decreased significantly, to the point where the cost of looking at the majority of a patient's genomic data may be less expensive than undertaking one or two targeted genetic tests. While efficient, the acquisition of this much genetic data - in some cases as many as 1.5 to 2 million variants - creates other challenges...
More...
More...